Aspen Aerogels (NYSE:ASPN) Sets New 12-Month High at $21.50

Aspen Aerogels, Inc. (NYSE:ASPN)’s share price hit a new 52-week high on Thursday . The company traded as high as $21.50 and last traded at $20.57, with a volume of 2639176 shares. The stock had previously closed at $15.22.

Analysts Set New Price Targets

Several research analysts have commented on the company. Roth Mkm reissued a “buy” rating and issued a $22.00 price objective on shares of Aspen Aerogels in a research report on Tuesday. TheStreet upgraded Aspen Aerogels from a “d+” rating to a “c-” rating in a report on Wednesday, March 6th. Canaccord Genuity Group upped their price target on Aspen Aerogels from $18.00 to $28.00 and gave the stock a “buy” rating in a report on Friday. B. Riley lifted their price objective on shares of Aspen Aerogels from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Friday. Finally, HC Wainwright raised their price target on shares of Aspen Aerogels from $20.00 to $25.00 and gave the company a “buy” rating in a report on Friday. One research analyst has rated the stock with a sell rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Aspen Aerogels has an average rating of “Moderate Buy” and a consensus price target of $25.17.

Aspen Aerogels Price Performance

The company has a debt-to-equity ratio of 0.24, a current ratio of 3.41 and a quick ratio of 2.91. The business’s 50-day moving average price is $16.72 and its two-hundred day moving average price is $13.69. The firm has a market cap of $1.93 billion, a price-to-earnings ratio of -57.09 and a beta of 1.97.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Tuesday, February 13th. The construction company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.54%. The company had revenue of $84.22 million during the quarter, compared to analyst estimates of $83.82 million. During the same period last year, the business earned ($0.20) EPS. On average, research analysts forecast that Aspen Aerogels, Inc. will post -0.24 EPS for the current fiscal year.

Hedge Funds Weigh In On Aspen Aerogels

Several large investors have recently added to or reduced their stakes in the company. Banque Cantonale Vaudoise raised its holdings in shares of Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after purchasing an additional 1,252 shares during the period. McAdam LLC bought a new position in Aspen Aerogels in the fourth quarter worth about $191,000. Mirae Asset Global Investments Co. Ltd. boosted its stake in Aspen Aerogels by 71.4% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company’s stock valued at $198,000 after acquiring an additional 9,601 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Aspen Aerogels by 38.5% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock valued at $205,000 after purchasing an additional 3,607 shares during the last quarter. Finally, Cornerstone Investment Partners LLC acquired a new stake in shares of Aspen Aerogels during the 4th quarter worth approximately $230,000. 97.64% of the stock is currently owned by institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.